Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe
Patient registries are a valuable tool in the research of rare conditions such as pulmonary hypertension (PH). We report comprehensive hemodynamic and survival data of 174 patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), included in the p...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-07-01
|
| Series: | Pulmonary Circulation |
| Online Access: | https://doi.org/10.1177/2045894018780521 |
| _version_ | 1811228098575728640 |
|---|---|
| author | Andris Skride Kristaps Sablinskis Aivars Lejnieks Ainars Rudzitis Irene Lang |
| author_facet | Andris Skride Kristaps Sablinskis Aivars Lejnieks Ainars Rudzitis Irene Lang |
| author_sort | Andris Skride |
| collection | DOAJ |
| description | Patient registries are a valuable tool in the research of rare conditions such as pulmonary hypertension (PH). We report comprehensive hemodynamic and survival data of 174 patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), included in the prospective Latvian PH registry over a period of > 9 years. In total, 130 adult PAH patients (75%) and 44 adult CTEPH patients (25%) were enrolled. The median follow-up period was 33 months for PAH and 18 months for CTEPH, P = 0.001. Latvian CTEPH patients had significantly higher plasma levels of B-type natriuretic peptide, higher pulmonary vascular resistance, and lower cardiac index than Latvian PAH patients. Calculated incidence of PAH and CTEPH in Latvia in 2016 was 13.7 and 5.1 cases per million inhabitants, calculated prevalence was 45.7 and 15.7 cases per million inhabitants, respectively. Survival rates at one, three, and five years for PAH patients was 88.0%, 73.3%, and 58.1%, and 83.8%, 59.0%, and 44.2% for CTEPH patients, respectively. We compared our study results with data from European adult PH registries. Latvian PAH patients had the fourth lowest and CTEPH patients the lowest one-year survival rate among European adult PH registries. As most PH registries in Europe are small, yet with equivalent patient inclusion criteria, it would be desirable to combine these registries to produce more reliable and high-quality study results. |
| first_indexed | 2024-04-12T09:52:47Z |
| format | Article |
| id | doaj.art-1fdf60f9ad58427d86bab566688a6ede |
| institution | Directory Open Access Journal |
| issn | 2045-8940 |
| language | English |
| last_indexed | 2024-04-12T09:52:47Z |
| publishDate | 2018-07-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pulmonary Circulation |
| spelling | doaj.art-1fdf60f9ad58427d86bab566688a6ede2022-12-22T03:37:47ZengWileyPulmonary Circulation2045-89402018-07-01810.1177/2045894018780521Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in EuropeAndris Skride0Kristaps Sablinskis1Aivars Lejnieks2Ainars Rudzitis3Irene Lang4Pauls Stradins Clinical University Hospital, Riga, LatviaPauls Stradins Clinical University Hospital, Riga, LatviaRiga East University Hospital, Riga, LatviaPauls Stradins Clinical University Hospital, Riga, LatviaVienna General Hospital, Medical University of Vienna, Vienna, AustriaPatient registries are a valuable tool in the research of rare conditions such as pulmonary hypertension (PH). We report comprehensive hemodynamic and survival data of 174 patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH), included in the prospective Latvian PH registry over a period of > 9 years. In total, 130 adult PAH patients (75%) and 44 adult CTEPH patients (25%) were enrolled. The median follow-up period was 33 months for PAH and 18 months for CTEPH, P = 0.001. Latvian CTEPH patients had significantly higher plasma levels of B-type natriuretic peptide, higher pulmonary vascular resistance, and lower cardiac index than Latvian PAH patients. Calculated incidence of PAH and CTEPH in Latvia in 2016 was 13.7 and 5.1 cases per million inhabitants, calculated prevalence was 45.7 and 15.7 cases per million inhabitants, respectively. Survival rates at one, three, and five years for PAH patients was 88.0%, 73.3%, and 58.1%, and 83.8%, 59.0%, and 44.2% for CTEPH patients, respectively. We compared our study results with data from European adult PH registries. Latvian PAH patients had the fourth lowest and CTEPH patients the lowest one-year survival rate among European adult PH registries. As most PH registries in Europe are small, yet with equivalent patient inclusion criteria, it would be desirable to combine these registries to produce more reliable and high-quality study results.https://doi.org/10.1177/2045894018780521 |
| spellingShingle | Andris Skride Kristaps Sablinskis Aivars Lejnieks Ainars Rudzitis Irene Lang Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe Pulmonary Circulation |
| title | Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe |
| title_full | Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe |
| title_fullStr | Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe |
| title_full_unstemmed | Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe |
| title_short | Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe |
| title_sort | characteristics and survival data from latvian pulmonary hypertension registry comparison of prospective pulmonary hypertension registries in europe |
| url | https://doi.org/10.1177/2045894018780521 |
| work_keys_str_mv | AT andrisskride characteristicsandsurvivaldatafromlatvianpulmonaryhypertensionregistrycomparisonofprospectivepulmonaryhypertensionregistriesineurope AT kristapssablinskis characteristicsandsurvivaldatafromlatvianpulmonaryhypertensionregistrycomparisonofprospectivepulmonaryhypertensionregistriesineurope AT aivarslejnieks characteristicsandsurvivaldatafromlatvianpulmonaryhypertensionregistrycomparisonofprospectivepulmonaryhypertensionregistriesineurope AT ainarsrudzitis characteristicsandsurvivaldatafromlatvianpulmonaryhypertensionregistrycomparisonofprospectivepulmonaryhypertensionregistriesineurope AT irenelang characteristicsandsurvivaldatafromlatvianpulmonaryhypertensionregistrycomparisonofprospectivepulmonaryhypertensionregistriesineurope |